Premium
Omalizumab in severe eczema
Author(s) -
Isaacs David
Publication year - 2020
Publication title -
journal of paediatrics and child health
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1111/jpc.15024
Subject(s) - omalizumab , medicine , placebo , atopic dermatitis , dermatology life quality index , randomized controlled trial , quality of life (healthcare) , immunoglobulin e , asthma , pediatrics , placebo controlled study , dermatology , double blind , antibody , immunology , alternative medicine , pathology , nursing , psoriasis